Insomnia is rarely a disorder of the bedroom alone. It sits at the intersection of stress physiology, circadian biology, gastrointestinal health, and systemic inflammation, and durable improvement often requires attention to each of these systems rather than reliance on a single hypnotic agent. A functional and integrative medicine framework, applied alongside rather than instead of evidence-based behavioral sleep medicine, offers a coherent way to organize this complexity and to individualize care for clients whose sleep has not responded to a purely symptomatic approach. https://www.ifmsynergy.com/insomnia-through-an-integrative-and-functional-medicine-lens/?fbclid=IwY2xjawS7MpNleHRuA2FlbQIxMQBzcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEeXKDoa5G46jHlJriMzH-Nz8ATwjRldc-Pb7cyDSVpDr2Y6HU1DgMhTD0Qfgs_aem_WKxuYzNR6QCi208WgonKLQ

When a mycotoxin profile flags citrinin (reported as its urinary metabolite dihydrocitrinone) or mycophenolic acid, the reflex in many clinics is to assume a water-damaged building and reach for binders. That reflex is sometimes right and often premature. Both of these toxins carry a substantial dietary and pharmacologic footprint that can drive a positive result with no indoor mold source at all. Sorting exposure into three buckets — environmental, dietary, and pharmacologic — before intervening is the difference between a targeted plan and a client committed to remediation and a binder protocol they may not need. https://www.ifmsynergy.com/two-overlooked-mycotoxins-on-your-panel-where-citrinin-and-mycophenolic-acid-come-from-and-how-to-work-them-up/?fbclid=IwY2xjawS6QSZleHRuA2FlbQIxMQBzcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEe05i-KeSneM1jQATgXZ5kE1y3Xd7SGaHzqNlHoxxstZeb5WsUiBMLAt0Cu54_aem_nmcFJ9qNbWz4VHFHviXMgw

Among the most clinically consequential single-nucleotide polymorphisms encountered in integrative and functional medicine practice is the COMT Val158Met (rs4680) variant. Catechol-O-methyltransferase (COMT) is the principal enzyme responsible for the metabolic degradation of catecholamines—dopamine, norepinephrine, and epinephrine—particularly within the prefrontal cortex, where dopamine transporter density is relatively sparse.1,2 Individuals homozygous for the Met allele (Met/Met, sometimes termed the “worrier” genotype) carry a COMT enzyme variant with approximately three- to four-fold lower catalytic activity compared to Val/Val homozygotes.3,4 While this confers certain cognitive advantages—enhanced working memory and executive function under baseline, low-stress conditions—it simultaneously creates vulnerability to catecholaminergic excess during periods of psychological or physiological stress. The clinical consequence is a characteristic phenotype: hyperarousal, heightened anxiety, difficulty with emotional regulation, and pronounced susceptibility to insomnia and sleep disruption.5 This article examines the molecular biochemistry underlying impaired COMT-mediated dopamine clearance and synthesizes the current evidence for targeted mitigation strategies, from methylation cofactor optimization to dietary modification and pharmacogenomic considerations.

Do you have any thoughts about neurodivergence and chronic illness, chronic pain, have been reading about more, and treatment?

You get a diagnosis. Maybe it's mast cell activation syndrome. Maybe it's fibromyalgia. Maybe it's long COVID. And you think — okay, now I know what I have. Now we treat it. But here's the thing most people don't hear: a diagnosis tells you what is happening. It doesn't always tell you why. In integrative medicine, we ask a different question. Not just — what do we call this? But — what got you here? What's keeping this active? Is there an underlying driver we haven't looked at yet? Take mast cell activation syndrome. Two patients can have the same diagnosis, but one was triggered by mold exposure, another by a post-viral immune shift. Same label. Completely different root paths. This doesn't mean we ignore your symptoms. We absolutely manage symptoms. But we also go deeper. We ask: what can we safely modify? What's driving the pattern? So if you've been diagnosed with something complex and you feel like you're only getting surface-level treatment — that's worth paying attention to. The label is useful. But the label is not the whole story.